Migraine Research Foundation   Report issue

Foundation Phase 1 Phase 2 Phase 3
Founded: New York NY United States (2006)

Organization Overview

First Clinical Trial
2013
NCT01389193
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Migraine Research Foundation